The 2020 Best of ASTRO meeting provided a review of the most relevant, highly-rated abstracts from the 2020 Annual Meeting that highlight recent technological advances and illustrate the importance of the clinical and non-clinical skills needed to provide patients with the full benefit of radiati

IJROBP Journal SA-CME activity for May 1, 2020 reviews the patient-reported outcomes of oligometastatic patients after conventional or stereotactic radiotherapy to bone metastases.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas and the use of radiation therapy for palliative purposes.

In patients receiving whole brain radiotherapy after surgical resection of brain metastasis, this article addresses the optimal radiotherapy dose for both tumor control and minimization of short and long-term toxicities.

Forty percent of radiation therapy in the United States is given with palliative intent. At the same time, palliative RT receives disproportionately low attention at national meetings, is not well studied on clinical protocols. Palliative RT remains more of an art than clinical science.

40% of radiation therapy in the United States is given with palliative intent. At the same time, palliative RT receives disproportionately low attention at national meetings, is not well studied on clinical protocols. Palliative RT remains more of an art than clinical science.

PRO Journal SA-CME activity for March-April, 2019 (Volume 9, Issue 2) provides practitioners with a review of factors influencing efficacy of radiotherapy in pain response of symptomatic bone metastases.  

IJROBP Journal SA-CME activity for March 15, 2019 (Volume 103, Issue 4) provides practitioners with the knowledge needed to optimize planning of stereotactic body radiotherapy to lung tumors and to provide evidence-based discussions to patients undergoing stereotactic body radiation ther